HUTCHMED China Ltd files list of directors to HKEX

Reuters
10/15
HUTCHMED China Ltd files list of directors to HKEX

HUTCHMED (China) Ltd. has filed an updated list of directors and their roles with the Hong Kong Stock Exchange. The Board comprises 10 directors, including Dr Dan Eldar as Chairman and Non-executive Director. Executive Directors are Dr Weiguo Su (Chief Executive Officer* and Chief Scientific Officer) and Mr Cheng Chig Fung, Johnny (Acting Chief Executive Officer and Chief Financial Officer). Non-executive Directors are Ms Edith Shih and Ms Ling Yang. Independent Non-executive Directors include Professor Mok Shu Kam, Tony (Senior and Lead Independent Non-executive Director), Dr Renu Bhatia, Dr Chaohong Hu, Professor Tan Shao Weng, Daniel, and Mr Wong Tak Wai. Committee memberships are as follows: - Audit Committee: Dr Renu Bhatia (Member), Dr Chaohong Hu (Member), Mr Wong Tak Wai (Chairman) - Nomination Committee: Dr Dan Eldar (Member), Dr Chaohong Hu (Member), Professor Mok Shu Kam, Tony (Chairman) - Remuneration Committee: Ms Edith Shih (Member), Dr Renu Bhatia (Chairman), Mr Wong Tak Wai (Member) - Sustainability Committee: Mr Cheng Chig Fung, Johnny (Member), Ms Edith Shih (Chairman), Professor Mok Shu Kam, Tony (Member) - Technical Committee: Dr Dan Eldar (Member), Dr Weiguo Su (Member), Dr Renu Bhatia (Member), Dr Chaohong Hu (Member), Professor Tan Shao Weng, Daniel (Member), Professor Mok Shu Kam, Tony (Chairman) *Dr Weiguo Su is currently on leave from his duties.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HUTCHMED (China) Ltd. published the original content used to generate this news brief on October 15, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10